NESH protein expression switches to the adverse effect of imatinib mesylate

被引：3
|
作者：
Matsuda, Satoru [1 ,2 ]
Ichigotani, Yasukatu [2 ,3 ]
Okumura, Naoko [1 ]
Yoshida, Hitomi [1 ]
Kajiya, Yuka [1 ]
Kitagishi, Yasuko [1 ]
Shirafuji, Naoki [4 ]
机构：
[1] Nara Womens Univ, Dept Environm Hlth, Nara 6308506, Japan
[2] Nagoya Univ, Sch Med, Dept Mol Pathogenesis, Nagoya, Aichi 4668550, Japan
[3] Hop Henri Mondor, INSERM, U841, F-94010 Creteil, France
[4] Teikyo Univ, Sch Med, Dept Hematol Oncol, Tokyo 173, Japan
来源：
MOLECULAR ONCOLOGY | 2008年 / 2卷 / 01期
关键词：
D O I：
10.1016/j.molonc.2008.03.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 19
页数：4
相关论文
共 50 条
  • [11] Hypolipemiant besides antileukemic effect of imatinib mesylate
    Gologan, Radu
    Constantinescu, Gabriela
    Georgescu, Daniela
    Ostroveanu, Daniela
    Vasilache, Didona
    Dobrea, Camelia
    Iancu, Daniela
    Popov, Viola
    [J]. LEUKEMIA RESEARCH, 2009, 33 (09) : 1285 - 1287
  • [12] Signal detection of visual and hearing adverse events associated with imatinib mesylate (Gleevec®)
    Petronella, Sharon A.
    Alexander, Victor
    Wilkinson, Gregg S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S259 - S260
  • [13] Gene expression signature may predict imatinib mesylate response
    不详
    [J]. PHARMACOGENOMICS, 2009, 10 (07) : 1129 - 1129
  • [14] Effect of Imatinib mesylate in gastric cancer cell progression
    Kim, Jung Lim
    Kim, Bo Ram
    Na, Yoo Jin
    Park, Seong Hye
    Jeong, Yoon A.
    Oh, Sang Cheul
    [J]. CANCER RESEARCH, 2015, 75
  • [15] Expression of imatinib mesylate-targeted kinases in endometrial carcinoma
    Slomovitz, BM
    Broaddus, RR
    Schmandt, R
    Wu, WG
    Oh, JC
    Ramondetta, LM
    Burke, TW
    Gershenson, DM
    Lu, KH
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 95 (01) : 32 - 36
  • [16] Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event
    HeLi Liu
    GuoQing Liao
    ZhongShu Yan
    [J]. BMC Gastroenterology, 11
  • [17] Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: arare adverse event
    Liu, HeLi
    Liao, GuoQing
    Yan, ZhongShu
    [J]. BMC GASTROENTEROLOGY, 2011, 11
  • [18] The effect of imatinib mesylate on the contractility of isolated rabbit myometrial strips
    Hutchings, G.
    Deprest, J.
    Nilius, B.
    Roskams, T.
    De Ridder, D.
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2006, 62 (02) : 79 - 83
  • [19] Effect of imatinib mesylate (IM) on endothelial cells (EC) functions
    Venalis, P.
    Distler, O.
    Akhmetshina, A.
    Dees, C.
    Buch, N.
    Gay, S.
    Schett, G.
    Distler, J. H. W.
    [J]. JOINT BONE SPINE, 2008, 75 (02) : 248 - 248
  • [20] Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
    Rink, Lori
    Skorobogatko, Yuliya
    Kossenkov, Andrew
    Belinsky, Martin
    Pajak, Thomas
    von Mehren, Margaret
    Ochs, Michael
    Eisenberg, Burton
    Godwin, Andrew
    [J]. CANCER RESEARCH, 2009, 69
12345